Perspective Therapeutics, Inc.CATXNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+28.6%
5Y CAGR+33.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+28.6%/yr
vs +20.0%/yr prior
5Y CAGR
+33.5%/yr
Recent deceleration
Acceleration
+8.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$30.23M+13.6%
2024$26.61M+26.3%
2023$21.06M+48.2%
2022$14.21M+50.8%
2021$9.43M+32.2%
2020$7.13M-5.5%
2019$7.55M+10.2%
2018$6.85M+0.4%
2017$6.83M+9.6%
2016$6.23M-